This video offers an introduction to the OMICROHN Study, developed within the Horizon Europe project METHYLOMIC, in which IFCCA is a participating member. With contributions from Prof. Jack Satsangi, Dr Alexandra Noble, Prof. Geert D’Haens, and patient representative Marieke Oosting, the video explores how epigenetics and DNA methylation could support a more personalised and forward-looking approach to inflammatory bowel disease care.
Subtitles
You can view the video with subtitles in English, Dutch, French, Italian, Hungarian and Slovanian (click on settings and choose your language).